McKesson Corporation vs Abbvie Inc.
MCK vs ABBV — side-by-side comparison from reported financials. MCK leads 7, ABBV leads 5 of 12 comparable metrics.
McKesson Corporation
MCK · Healthcare
$938.84+0.92%Solid
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | MCK | ABBV |
|---|---|---|
| Price | $938.84 | $276.43 |
| Market cap | $109B | $488B |
| Revenue (TTM) | $411B | $64.4B |
| Revenue growth | +13.4% | +1.8% |
| Net margin | 1.1% | 9.8% |
| Free cash flow | $6.42B | $18.2B |
| Net cash (debt) | ($4.81B) | ($56.2B) |
| 1-year price return | +23.9% | +19.8% |
| P/E | 23.8 | 77.4 |
| P/E vs own history (cheap-side %) | 59% | 23% |
| Dividend yield | 0.36% | 2.45% |
| Return on equity | 39% | 96% |
| Altman Z-score | 2.25 | 2.33 |
| CV checks passed | 11 of 11 | 9 of 11 |
| Employees | 43,000 | 57,000 |
Full résumé-style profiles: MCK CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.